Alnylam Sweden AB
559086-6686ActiveLeading RNAi therapeutics company developing gene-silencing medicines.
Oversikt
- 5–9
- Ansatte
- 100–500mill SEK
- Omsetning
- 2016
- Grunnlagt
Beskrivelse
Alnylam Pharmaceuticals is a leading global biopharmaceutical company dedicated to pioneering RNA interference (RNAi) therapeutics. They focus on developing an innovative class of medicines designed to treat diseases by silencing the specific genes responsible for causing them. This mechanism target...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Partihandel med medicinsk utrustning och apoteksvaror
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559086668601
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAlexion Pharma Nordics AB
10–19 ansattePioneering transformative medicines for the global rare disease community.
Purpose Pharma International AB
5–9 ansatteDeveloping and supplying rare disease treatments across Europe.
PTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
ASTRAZENECA PLC
Global science-led pharmaceutical business developing life-changing medicines.
ScandiBio Therapeutics AB
0 ansatteAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Utforsk mer
Spørsmål om Alnylam Sweden AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo